As of March 16, all research visits were suspended for the studies run through the CU Alzheimer’s and Cognition Center. Our research staff is in the process of reaching out to all participants of research studies that are affected by this suspension in the next few weeks to reschedule for later in the year, with the knowledge that changes will be ongoing and that schedules will need to be flexible. We are developing strategies for reopening recruitment of new participants once it is safe to resume operations on our campus.
We appreciate your understanding and patience as we continue to adapt to this rapidly evolving situation. As always, our patients’ and our research participants’ safety is of the utmost importance to us, and we will always put that first. In the coming weeks and months, we will continue to monitor the spread of COVID-19 and will update our research studies and clinical practices accordingly. We look forward to resuming normal operating procedures as soon as possible. In the meantime, please follow the CDC guidelines and stay safe.
The Colorado Aging Brain Lab is composed of a team of researchers dedicated to understanding the neuroscience of the aging brain through an array of observational studies. As a part of the Rocky Mountain Alzheimer’s Disease Center at the University of Colorado Anschutz Medical campus, the goal of our laboratory is to better understand what puts us at risk for Alzheimer’s disease, as well as what protects us from Alzheimer’s disease. We believe we have as much to learn from individuals who are healthy and have no symptoms of a memory disorder as we do from individuals who are experiencing cognitive decline as they grow older.
University of Colorado Alzheimer’s and Cognition Center (CUACC)
The Colorado Aging Brain lab is one of the research laboratories that makes up the University of Colorado Alzheimer’s and Cognition Center at the Anschutz Medical Campus. This center is the regional headquarters for dementia research and clinical care. To learn more about how our lab fits into the CUACC’s vision to contribute to the end of Alzheimer’s disease, click here.